Chief Financial Officer

Vice President, Clinical Research and Regulatory Affairs

Arcellx resumed with a Buy at Stifel

Arcellx assumed with a Neutral at Cantor Fitzgerald

Arcellx Insider Sold Shares Worth $1,709,723, According to a Recent SEC Filing

Arcellx's Chief Medical Officer Sells Shares

Medical Science Liaison

Arcellx is a public, clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies. The Medical Science Liaison (MSL) will serve as a key scientific resource and expert on cell therapy, establishing relationships with healthcare professionals and facilitating medical education.

Medical Science Liaison (Carolinas)

Chief People Officer

Senior Medical Science Liaison

Sign up with Google

Sign in with Google